PanSurg COVesity

Obesity and COVID-19 related workstreams, resources and research.


The obesity pandemic has been a burden globally for decades. The current COVID-19 pandemic has superimposed its morbidity, especially on those with the disease of obesity and obesity-related comorbidities such as type 2 diabetes.

The COVID and Obesity (COVesity) pandemic will have a considerable impact for some time, and the behavioural change around controlling the spread of COVID-19 is already leading to a reduction in activity, poorer food choices and a new spike in obesity. These 2 pandemics must be contained together.

To understand this unique relationship, PanSurg has created obesity-related workstreams, resources and research on this important subject. The COMS-UK and CONSULT-19 studies will allow data collection on service-provision and training in obesity services and our webinar has already highlighted the important areas of concern.

Once bariatric surgery recommences in the UK and other places, it will be important to collect data on outcomes and morbidities related to COIVD-19 and to share best new practices in order to make surgery as safe as possible.

Impact of COVID-19 on Obesity Management Services in the UK

COMS-UK is a cross-sectional survey assessing the impact of COVID-19 on the delivery of bariatric services around the UK.

We want to involve all healthcare professionals caring for bariatric patients in the UK.

Consequences ON SUrgicaL Training from the COVID-19 Pandemic

The CONSULT-19 survey has been developed by trainees for trainees, to understand the impact COVID will have on our career progression.

This short survey allows us to better evaluate the loss of training through redeployment and cancellation of elective lists. Our findings will be shared with all relevant training bodies to help define training in the coming months.

COVesity Team